Monitoring of Thromboembolic Events Prophylaxis: Where Do We Stand?

Abstract

Background: Thromboembolic events are one of the most important causes of mortality in the hospitalized patients. Evaluation of anticoagulants intake patterns compared to the standard treatment guidelines is necessary for improving the quality of prophylaxis managements. The present study was performed to evaluate the pattern of heparin and enoxaparin intake compared to the standard treatment guidelines for thromboprophylaxis.

Methods: The present study was conducted on 305 patients admitted to the two referral teaching hospitals. The patients were classified according to the treatment guidelines of American College of Chest Physicians and based on the type of risk (low, moderate, and high). Finally, prophylaxis regimen was assessed based on the standard treatment guidelines and the intervention was performed in case of contradiction.

Results: In this study, averagely, prophylactic regimen showed 83.3% compliance with the standard treatment guidelines. Moreover, 188 patients (61.6%) were in moderate and high risk groups and needed prophylaxis therapy. Among these patients, 93% (175 patients) received appropriate prophylaxis. According to the results, being above 40 years old, infection, and inactivity were the most important risk factors in the patients with the prevalence of 81.6%, 47.9%, and 43.3%, respectively.

Conclusion: Although treatment guidelines are available for the prophylaxis of thromboembolic events, prophylaxis regimens are not always administered in accordance with these guidelines. Failure to observe these guidelines could increase the cost of treatment and risk of thrombosis as well as other serious problems for the patients.




J Hematol. 2015;4(4):223-227
doi: http://dx.doi.org/10.14740/jh232e